Related Articles
mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review)
Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)
Targeted therapy for gastric cancer: Current status and future directions (Review)
Anti‑proliferative effect of cardamonin on mTOR inhibitor‑resistant cancer cells
Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1